Ekso Bionics Holdings (NASDAQ:EKSO) has announced that it has successfully demonstrated initial proof-of-concept in integrating new AI-enabled capabilities across its portfolio of Enterprise Health and Personal Health exoskeleton devices.
The first of these capabilities is a new AI voice agent designed for intelligent control of the Company’s legacy EksoNR device. Ekso Voice Agent is being implemented on NVIDIA Jetson Orin Nano hardware developed with the NVIDIA JetPack SDK and OpenAI tools for voice recognition. The proof-of-concept is configured as an Edge AI system, which can run with or without a connection to the cloud.
In a statement, Scott Davis, CEO of Ekso Bionics, said, “We are actively developing AI tools to leverage our existing data and expertise to transform human-robot interaction, which we believe is a necessary component to enable broader adoption of exoskeletons for personal use. Integration of voice agent capabilities into our existing devices is just one example of the advances we are investigating.”
Mr. Davis added, “With a data repository consisting of approximately 350,000 patient sessions and over 15 million step-by-step data points, which is growing by an additional 60,000 patient steps on average every day, we believe that we are uniquely positioned to utilize AI to advance exoskeleton technology platforms.”
Ekso’s first proof-of-concept demonstration comes just over a month after the company announced its acceptance into the NVIDIA Connect Program.
NVIDIA Connect is a selective program that brings together emerging and established technology companies to accelerate product development and increase cost efficiency. Members gain specialized training, priority engineering support, and exclusive access to NVIDIA’s (NASDAQ:NVDA) advanced development kits, GPU platforms, and global ecosystem, helping them deliver next-generation solutions in AI and high-performance computing.
